Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 83.01%16.16M | 479.22%11.07M | -23.77%1.57M | -23.17%1.79M | -31.75%1.72M | -16.19%8.83M | -34.27%1.91M | -14.18%2.07M | -15.75%2.33M | 2.76%2.53M |
Selling and administrative expenses | -2.33%3.16M | 31.22%1.15M | -21.19%590.62K | -10.32%657.81K | -13.12%757.28K | 9.70%3.23M | 8.73%876.4K | 11.01%749.47K | 7.10%733.5K | 11.86%871.68K |
-General and administrative expense | -2.33%3.16M | 31.22%1.15M | -21.19%590.62K | -10.32%657.81K | -13.12%757.28K | 9.70%3.23M | 8.73%876.4K | 11.01%749.47K | 7.10%733.5K | 11.86%871.68K |
Research and development costs | 132.24%13.01M | 858.35%9.92M | -25.24%984.28K | -29.08%1.13M | -41.57%966.11K | -26.23%5.6M | -50.76%1.04M | -24.00%1.32M | -23.27%1.59M | -1.46%1.65M |
Operating profit | -83.01%-16.16M | -479.22%-11.07M | 23.77%-1.57M | 23.17%-1.79M | 31.75%-1.72M | 16.19%-8.83M | 34.27%-1.91M | 14.18%-2.07M | 15.75%-2.33M | -2.76%-2.53M |
Net non-operating interest income expense | -5.83%404.02K | 51.96%149.04K | -11.51%99.34K | -42.70%73.48K | -9.20%82.17K | 1,920.05%429.04K | 674.67%98.07K | 1,358.30%112.26K | 30,647.72%128.22K | 19,401.72%90.49K |
Non-operating interest income | -5.83%404.02K | 51.96%149.04K | -11.51%99.34K | -42.70%73.48K | -9.20%82.17K | 1,920.05%429.04K | 674.67%98.07K | 1,358.30%112.26K | 30,647.72%128.22K | 19,401.72%90.49K |
Other net income (expense) | 171.28K | 0 | 171.28K | |||||||
Other non- operating income (expenses) | --171.28K | --0 | --171.28K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Income before tax | -85.50%-15.59M | -502.32%-10.93M | 33.24%-1.3M | 22.03%-1.72M | 32.59%-1.64M | 20.10%-8.4M | 37.37%-1.81M | 18.58%-1.95M | 20.37%-2.2M | 0.90%-2.43M |
Income tax | ||||||||||
Net income | -85.50%-15.59M | -502.32%-10.93M | 33.24%-1.3M | 22.03%-1.72M | 32.59%-1.64M | 20.10%-8.4M | 37.37%-1.81M | 18.58%-1.95M | 20.37%-2.2M | 0.90%-2.43M |
Net income continuous Operations | -85.50%-15.59M | -502.32%-10.93M | 33.24%-1.3M | 22.03%-1.72M | 32.59%-1.64M | 20.10%-8.4M | 37.37%-1.81M | 18.58%-1.95M | 20.37%-2.2M | 0.90%-2.43M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -85.50%-15.59M | -502.32%-10.93M | 33.24%-1.3M | 22.03%-1.72M | 32.59%-1.64M | 20.10%-8.4M | 37.37%-1.81M | 18.58%-1.95M | 20.37%-2.2M | 0.90%-2.43M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -85.50%-15.59M | -502.32%-10.93M | 33.24%-1.3M | 22.03%-1.72M | 32.59%-1.64M | 20.10%-8.4M | 37.37%-1.81M | 18.58%-1.95M | 20.37%-2.2M | 0.90%-2.43M |
Basic earnings per share | -35.20%-4.11 | -350.82%-2.75 | 46.38%-0.37 | 37.50%-0.5 | 47.37%-0.5 | 26.75%-3.04 | 46.96%-0.61 | 27.37%-0.69 | 27.27%-0.8 | 0.00%-0.95 |
Diluted earnings per share | -35.20%-4.11 | -350.82%-2.75 | 46.38%-0.37 | 37.50%-0.5 | 47.37%-0.5 | 26.75%-3.04 | 46.96%-0.61 | 27.37%-0.69 | 27.27%-0.8 | 0.00%-0.95 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |